English
|
Spanish
Login
Register
The content on this site is intended for healthcare professionals only
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[130]
News
[236]
Articles
[14]
Editorials
[3]
Conferences
[41]
e
learning
[17]
Reasons to attend the EurocanPlatform translational research course 2015
Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany
6 Jan 2015
2nd EurocanPlatform translational research course is good for networking
Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal
6 Jan 2015
Biobanking biological materials and linkage to clinical information
Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands
6 Jan 2015
The role of health economics in cancer outcomes research
Prof Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden
6 Jan 2015
Summary of breaking prostate news from ASCO 2014
Prof Eleni Efstathiou and Prof Gordon McVie
2 Jun 2014
Mantle cell lymphoma: A review of data and expert opinion from ASCO 2014
Prof Franco Cavalli, Prof Gordon McVie
1 Jun 2014
Idelalisib shows promising results in patients with double refractory indolent B...
Dr Andrew Davies - Southampton General Hospital, Southampton, UK;
9 May 2014
New agents extend progression-free survival in double refractory myeloma
Dr Jonathan Kaufman - Winship Cancer Institute of Emory University, Atlanta, US...
8 May 2014
Role of AORTIC in dealing with rising cancer rates in Africa
North American Vice president of AORTIC
1 May 2014
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bo...
Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden
1 Feb 2014
<
1
...
7
8
9
10
11
>
More from
e
cancer